COVID-19

The Italian Medicines Agency publishes Guidance on the management of clinical trials in Italy during the COVID-19 emergency

By Bart Van Vooren on March 30, 2020

Posted in European Union, Food & Drug Regulatory, Medicinal Products

On March 12, 2020, the Italian Medicines Agency (“AIFA”) has provided guidance on the management of clinical trials due to the COVID-19 emergency. The Guidance, which is addressed to CROs, Sponsors and non-profit organizations involved in clinical trials, allows for some derogations to support them face the criticalities. The Guidance…
Continue Reading The Italian Medicines Agency publishes Guidance on the management of clinical trials in Italy during the COVID-19 emergency